missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Clofibrate 100 μg/mL in Acetonitrile, Dr. Ehrenstorfer
Tekniske data
Tekniske data
| Kemisk navn eller materiale | Ethyl clofibrate |
| CAS | 637-07-0 |
| Analyt- eller komponentnavne | Ethyl clofibrate |
| Forsendelsestilstand | +20°C |
| Molekylær formel | C12 H15 Cl O3 |
| Koncentration | 100 μg/mL |
| Certificeringer/compliance | ISO 17034 |
| Synonym | Clofibrate, Ethyl 2-(4-chlorophenoxy)-2-methylpropionate, 2-(4-Chlorophenoxy)-2-methyl-propanoic acid ethyl ester, Propionic acid, 2-(p-chlorophenoxy)-2-methyl-, ethyl ester (6CI,8CI), 2-(4-Chlorophenoxy)isobutyric acid ethyl ester, 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester, AY 61123, Abitrate, Amotril, Anparton, Apolan, Arteriosan, Artevil, Ateculon, Ateriosan, Atheropront, Atromid S, Atromidin, Azionyl, Bioscleran, CPIB, Cartagyl, Claripex, Claripex CPIB, Clobren SF, Clofibrat, Clofinit, ECPIB, EPIB, Ethyl 2-(4-chlorophenoxy)isobutyrate, Ethyl 2-(p-chlorophenoxy)-2-methylpropionate, Ethyl 2-(p-chlorophenoxy)isobutyrate, Ethyl clofibrate, Ethyl p-chlorophenoxyisobutyrate, Hyclorate, ICI 28257, Lipavil, Lipavlon, Lipomid, Liprinal, Miscleron, Misclerone, NSC 79389, Neo-Atromid, Normet, Normolipol, Recolip, Regelan, Serotinex, Sklerepmexe, Sklero-Tablinene, Sklerolip, Skleromexe, Ticlobran, Xyduril, p-Chlorophenoxyisobutyric acid ethyl ester, Ethyl alpha-(4-chlorophenoxy)-alpha-methylpropionate, Ethyl alpha-(4-chlorophenoxy)isobutyrate, Ethyl alpha-(p-chlorophenoxy)-alpha-methylpropionate, Ethyl alpha-(p-chlorophenoxy)isobutyrate |
| InChI formel | InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3 |
| SMIL | CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 |
| Vis mere |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?